Tag: glioma
Onxeo: inclusion of the 1st patient in the phase 1b/2 clinical trial in recurrent high-grade glioma in children – 09/01/2022 at 20:15
Recurrent high-grade glioma in children: Onxeo announces the inclusion of the 1st patient in the phase 1b/2 clinical trial conducted by the European consortium ITCC, with the support of Institut…
Novartis: Positive data in pediatric glioma
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Novartis: positive data in pediatric glioma
(CercleFinance.com) – Novartis announces that its Tafinlar-Mekinist combination has demonstrated ‘unprecedented efficacy’ in patients aged one to 17 years with BRAF V600 low-grade pediatric glioma requiring initial systemic therapy, compared…